145 related articles for article (PubMed ID: 25096798)
1. Fetal radiation monitoring and dose minimization during intensity modulated radiation therapy for glioblastoma in pregnancy.
Horowitz DP; Wang TJ; Wuu CS; Feng W; Drassinower D; Lasala A; Pieniazek R; Cheng S; Connolly EP; Lassman AB
J Neurooncol; 2014 Nov; 120(2):405-9. PubMed ID: 25096798
[TBL] [Abstract][Full Text] [Related]
2. [A special radiation shielding for the radiotherapy of a pregnant patient].
Buchgeister M; Mondry A; Spillner P; Paulsen F; Belka C; Bamberg M
Strahlenther Onkol; 2008 Feb; 184(2):80-5. PubMed ID: 18259699
[TBL] [Abstract][Full Text] [Related]
3. Radiation treatment planning and delivery strategies for a pregnant brain tumor patient.
Labby ZE; Barraclough B; Bayliss RA; Besemer AE; Dunkerley DAP; Howard SP
J Appl Clin Med Phys; 2018 Sep; 19(5):368-374. PubMed ID: 30062720
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a new foetal shielding device for pregnant brain tumour patients.
Kang S; Kim KH; Kang SW; Shin DS; Lee S; Chung JB
Radiat Oncol; 2021 Jun; 16(1):109. PubMed ID: 34120633
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
[TBL] [Abstract][Full Text] [Related]
7. Sparing of normal tissues with volumetric arc radiation therapy for glioblastoma: single institution clinical experience.
Briere TM; McAleer MF; Levy LB; Yang JN
Radiat Oncol; 2017 May; 12(1):79. PubMed ID: 28464840
[TBL] [Abstract][Full Text] [Related]
8. Cardiac avoidance in breast radiotherapy: a comparison of simple shielding techniques with intensity-modulated radiotherapy.
Landau D; Adams EJ; Webb S; Ross G
Radiother Oncol; 2001 Sep; 60(3):247-55. PubMed ID: 11514004
[TBL] [Abstract][Full Text] [Related]
9. Photon-beam radiotherapy in pregnant patients: can the fetal dose be limited to 10 cGy or less?
Kourinou KM; Mazonakis M; Lyraraki E; Damilakis J
Phys Med; 2015 Feb; 31(1):85-91. PubMed ID: 25455441
[TBL] [Abstract][Full Text] [Related]
10. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
11. Cerebral cortex dose sparing for glioblastoma patients: IMRT versus robust treatment planning.
Exeli AK; Kellner D; Exeli L; Steininger P; Wolf F; Sedlmayer F; Deutschmann H
Radiat Oncol; 2018 Feb; 13(1):20. PubMed ID: 29409516
[TBL] [Abstract][Full Text] [Related]
12. Investigation of conformal and intensity-modulated radiation therapy techniques to determine the absorbed fetal dose in pregnant patients with breast cancer.
Öğretici A; Akbaş U; Köksal C; Bilge H
Med Dosim; 2016; 41(2):95-9. PubMed ID: 26831923
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric advantage of intensity-modulated radiotherapy for whole ventricles in the treatment of localized intracranial germinoma.
Sakanaka K; Mizowaki T; Hiraoka M
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e273-80. PubMed ID: 21640515
[TBL] [Abstract][Full Text] [Related]
14. Fetal dose measurements and shielding efficiency assessment in a custom setup of (192)Ir brachytherapy for a pregnant woman with breast cancer.
Candela-Juan C; Gimeno-Olmos J; Pujades MC; Rivard MJ; Carmona V; Lliso F; Celada F; Ramírez-Coves JL; Ballester F; Tormo A; Perez-Calatayud J
Phys Med; 2015 May; 31(3):286-92. PubMed ID: 25681030
[TBL] [Abstract][Full Text] [Related]
15. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT.
Reft CS; Runkel-Muller R; Myrianthopoulos L
Med Phys; 2006 Oct; 33(10):3734-42. PubMed ID: 17089839
[TBL] [Abstract][Full Text] [Related]
16. Fetal dose estimates for radiotherapy of brain tumors during pregnancy.
Sneed PK; Albright NW; Wara WM; Prados MD; Wilson CB
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):823-30. PubMed ID: 7790270
[TBL] [Abstract][Full Text] [Related]
17. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
[TBL] [Abstract][Full Text] [Related]
18. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
19. Fetal dose evaluation during breast cancer radiotherapy.
Antypas C; Sandilos P; Kouvaris J; Balafouta E; Karinou E; Kollaros N; Vlahos L
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):995-9. PubMed ID: 9531386
[TBL] [Abstract][Full Text] [Related]
20. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
